Do analysts recommend CRD.B or CRD.A?

Crawford & Company has a consensus target price of $14.00, indicating a potential upside of 23.81%. Given Crawford & Company's stronger consensus rating and higher probable upside, analysts clearly believe Crawford & Company is more favorable than Crawford & Company. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crawford & Company 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Crawford & Company 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has higher earnings & valuation, CRD.B or CRD.A?

Crawford & Company is trading at a lower price-to-earnings ratio than Crawford & Company, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Crawford & Company $1.31B 0.39 $19.63M $0.36 28.94 Crawford & Company $1.31B 0.42 $19.63M $0.36 31.41

Is CRD.B or CRD.A more profitable?

Company Net Margins Return on Equity Return on Assets Crawford & Company 1.37% 24.21% 5.46% Crawford & Company 1.37% 24.21% 5.46%

Crawford & Company (CRD.A) Competitors

$11.31 +0.12 (+1.05%)

Closing price 07/28/2026 03:59 PM Eastern

Extended Trading

$11.30 -0.01 (-0.06%)

As of 04:01 AM Eastern

Compare

CRD.A vs. CRD.B, HCSG, CNXC, BV, and WLDN

Should you buy Crawford & Company stock or one of its competitors? MarketBeat compares Crawford & Company with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Crawford & Company include Crawford & Company (CRD.B), Healthcare Services Group (HCSG), Concentrix (CNXC), BrightView (BV), and Willdan Group (WLDN). These companies are all part of the "business svcs" industry.

How does Crawford & Company compare to Crawford & Company?

Crawford & Company (NYSE:CRD.B) and Crawford & Company (NYSE:CRD.A) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations, dividends and media sentiment.

Crawford & Company has a consensus target price of $14.00, indicating a potential upside of 23.81%. Given Crawford & Company's stronger consensus rating and higher probable upside, analysts clearly believe Crawford & Company is more favorable than Crawford & Company.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crawford & Company	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Crawford & Company	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Company	Net Margins	Return on Equity	Return on Assets
Crawford & Company	1.37%	24.21%	5.46%
Crawford & Company	1.37%	24.21%	5.46%

11.0% of Crawford & Company shares are held by institutional investors. Comparatively, 22.6% of Crawford & Company shares are held by institutional investors. 51.0% of Crawford & Company shares are held by insiders. Comparatively, 54.3% of Crawford & Company shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Crawford & Company had 1 more articles in the media than Crawford & Company. MarketBeat recorded 1 mentions for Crawford & Company and 0 mentions for Crawford & Company. Crawford & Company's average media sentiment score of 0.68 beat Crawford & Company's score of 0.00 indicating that Crawford & Company is being referred to more favorably in the media.

Company	Overall Sentiment
Crawford & Company	Positive
Crawford & Company	Neutral

Crawford & Company pays an annual dividend of $0.30 per share and has a dividend yield of 2.9%. Crawford & Company pays an annual dividend of $0.30 per share and has a dividend yield of 2.7%. Crawford & Company pays out 83.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crawford & Company pays out 83.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Crawford & Company has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market. Comparatively, Crawford & Company has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

Crawford & Company is trading at a lower price-to-earnings ratio than Crawford & Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crawford & Company	$1.31B	0.39	$19.63M	$0.36	28.94
Crawford & Company	$1.31B	0.42	$19.63M	$0.36	31.41

Summary

Crawford & Company beats Crawford & Company on 10 of the 13 factors compared between the two stocks.

How does Crawford & Company compare to Healthcare Services Group?

Crawford & Company (NYSE:CRD.A) and Healthcare Services Group (NASDAQ:HCSG) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends and media sentiment.

22.6% of Crawford & Company shares are held by institutional investors. Comparatively, 98.0% of Healthcare Services Group shares are held by institutional investors. 54.3% of Crawford & Company shares are held by insiders. Comparatively, 2.9% of Healthcare Services Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Healthcare Services Group had 14 more articles in the media than Crawford & Company. MarketBeat recorded 14 mentions for Healthcare Services Group and 0 mentions for Crawford & Company. Healthcare Services Group's average media sentiment score of 0.92 beat Crawford & Company's score of 0.00 indicating that Healthcare Services Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Crawford & Company	Neutral
Healthcare Services Group	Positive

Crawford & Company currently has a consensus price target of $14.00, indicating a potential upside of 23.81%. Healthcare Services Group has a consensus price target of $26.20, indicating a potential upside of 10.32%. Given Crawford & Company's stronger consensus rating and higher probable upside, equities analysts plainly believe Crawford & Company is more favorable than Healthcare Services Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crawford & Company	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Healthcare Services Group	0 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.63

Healthcare Services Group has higher revenue and earnings than Crawford & Company. Healthcare Services Group is trading at a lower price-to-earnings ratio than Crawford & Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crawford & Company	$1.31B	0.42	$19.63M	$0.36	31.41
Healthcare Services Group	$1.84B	0.89	$59.06M	$1.72	13.81

Healthcare Services Group has a net margin of 6.59% compared to Crawford & Company's net margin of 1.37%. Crawford & Company's return on equity of 24.21% beat Healthcare Services Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crawford & Company	1.37%	24.21%	5.46%
Healthcare Services Group	6.59%	18.97%	11.96%

Crawford & Company has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market. Comparatively, Healthcare Services Group has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market.

Summary

Healthcare Services Group beats Crawford & Company on 10 of the 16 factors compared between the two stocks.

How does Crawford & Company compare to Concentrix?

Crawford & Company (NYSE:CRD.A) and Concentrix (NASDAQ:CNXC) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

22.6% of Crawford & Company shares are held by institutional investors. Comparatively, 90.3% of Concentrix shares are held by institutional investors. 54.3% of Crawford & Company shares are held by company insiders. Comparatively, 0.9% of Concentrix shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Crawford & Company has higher earnings, but lower revenue than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than Crawford & Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crawford & Company	$1.31B	0.42	$19.63M	$0.36	31.41
Concentrix	$9.83B	0.16	-$1.28B	-$21.32	N/A

Crawford & Company has a net margin of 1.37% compared to Concentrix's net margin of -13.16%. Crawford & Company's return on equity of 24.21% beat Concentrix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crawford & Company	1.37%	24.21%	5.46%
Concentrix	-13.16%	19.82%	5.62%

Crawford & Company has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market. Comparatively, Concentrix has a beta of 0.47, suggesting that its stock price is 53% less volatile than the broader market.

Crawford & Company presently has a consensus price target of $14.00, suggesting a potential upside of 23.81%. Concentrix has a consensus price target of $32.75, suggesting a potential upside of 28.89%. Given Concentrix's higher probable upside, analysts clearly believe Concentrix is more favorable than Crawford & Company.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crawford & Company	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Concentrix	2 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.17

In the previous week, Concentrix had 12 more articles in the media than Crawford & Company. MarketBeat recorded 12 mentions for Concentrix and 0 mentions for Crawford & Company. Concentrix's average media sentiment score of 0.96 beat Crawford & Company's score of 0.00 indicating that Concentrix is being referred to more favorably in the news media.

Company	Overall Sentiment
Crawford & Company	Neutral
Concentrix	Positive

Crawford & Company pays an annual dividend of $0.30 per share and has a dividend yield of 2.7%. Concentrix pays an annual dividend of $1.44 per share and has a dividend yield of 5.7%. Crawford & Company pays out 83.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Concentrix pays out -6.8% of its earnings in the form of a dividend. Concentrix has raised its dividend for 3 consecutive years. Concentrix is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Concentrix beats Crawford & Company on 10 of the 19 factors compared between the two stocks.

How does Crawford & Company compare to BrightView?

BrightView (NYSE:BV) and Crawford & Company (NYSE:CRD.A) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

BrightView has a net margin of 1.70% compared to Crawford & Company's net margin of 1.37%. Crawford & Company's return on equity of 24.21% beat BrightView's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightView	1.70%	7.25%	2.73%
Crawford & Company	1.37%	24.21%	5.46%

BrightView has a beta of 1.17, meaning that its stock price is 17% more volatile than the broader market. Comparatively, Crawford & Company has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market.

92.4% of BrightView shares are held by institutional investors. Comparatively, 22.6% of Crawford & Company shares are held by institutional investors. 2.8% of BrightView shares are held by company insiders. Comparatively, 54.3% of Crawford & Company shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

BrightView has higher revenue and earnings than Crawford & Company. BrightView is trading at a lower price-to-earnings ratio than Crawford & Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightView	$2.67B	0.49	$56M	-$0.07	N/A
Crawford & Company	$1.31B	0.42	$19.63M	$0.36	31.41

In the previous week, BrightView had 2 more articles in the media than Crawford & Company. MarketBeat recorded 2 mentions for BrightView and 0 mentions for Crawford & Company. BrightView's average media sentiment score of 0.00 equaled Crawford & Company'saverage media sentiment score.

Company	Overall Sentiment
BrightView	Neutral
Crawford & Company	Neutral

BrightView currently has a consensus target price of $14.52, suggesting a potential upside of 3.58%. Crawford & Company has a consensus target price of $14.00, suggesting a potential upside of 23.81%. Given Crawford & Company's stronger consensus rating and higher possible upside, analysts plainly believe Crawford & Company is more favorable than BrightView.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightView	3 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.22
Crawford & Company	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

BrightView beats Crawford & Company on 9 of the 16 factors compared between the two stocks.

How does Crawford & Company compare to Willdan Group?

Willdan Group (NASDAQ:WLDN) and Crawford & Company (NYSE:CRD.A) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

Willdan Group has a net margin of 8.24% compared to Crawford & Company's net margin of 1.37%. Crawford & Company's return on equity of 24.21% beat Willdan Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Willdan Group	8.24%	23.36%	13.28%
Crawford & Company	1.37%	24.21%	5.46%

72.3% of Willdan Group shares are owned by institutional investors. Comparatively, 22.6% of Crawford & Company shares are owned by institutional investors. 5.6% of Willdan Group shares are owned by insiders. Comparatively, 54.3% of Crawford & Company shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Willdan Group presently has a consensus target price of $112.67, indicating a potential upside of 60.91%. Crawford & Company has a consensus target price of $14.00, indicating a potential upside of 23.81%. Given Willdan Group's higher possible upside, equities analysts plainly believe Willdan Group is more favorable than Crawford & Company.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Willdan Group	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00
Crawford & Company	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Willdan Group had 3 more articles in the media than Crawford & Company. MarketBeat recorded 3 mentions for Willdan Group and 0 mentions for Crawford & Company. Willdan Group's average media sentiment score of 1.40 beat Crawford & Company's score of 0.00 indicating that Willdan Group is being referred to more favorably in the media.

Company	Overall Sentiment
Willdan Group	Positive
Crawford & Company	Neutral

Willdan Group has higher earnings, but lower revenue than Crawford & Company. Willdan Group is trading at a lower price-to-earnings ratio than Crawford & Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Willdan Group	$684.28M	1.55	$52.56M	$3.71	18.87
Crawford & Company	$1.31B	0.42	$19.63M	$0.36	31.41

Willdan Group has a beta of 1.13, meaning that its share price is 13% more volatile than the broader market. Comparatively, Crawford & Company has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market.

Summary

Willdan Group beats Crawford & Company on 12 of the 16 factors compared between the two stocks.

Get Crawford & Company News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRD.A and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRD.A vs. The Competition

Export

Metric	Crawford & Company	BUSINESS SVCS Industry	Business Sector	NYSE Exchange
Market Cap	$545.41M	$5.92B	$6.88B	$23.66B
Dividend Yield	2.68%	2.92%	3.05%	4.20%
P/E Ratio	31.41	11.96	28.22	31.08
Price / Sales	0.42	1.46	301.73	14.27
Price / Cash	6.41	11.74	23.09	31.92
Price / Book	3.22	4.97	5.62	4.83
Net Income	$19.63M	$154.26M	$205.80M	$1.07B
7 Day Performance	5.88%	1.14%	1.27%	0.69%
1 Month Performance	-3.14%	-2.55%	-2.63%	0.89%
1 Year Performance	12.80%	-6.84%	6.27%	15.67%

Crawford & Company Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRD.A Crawford & Company	2.0436 of 5 stars	$11.31 +1.1%	$14.00 +23.8%	+7.4%	$545.41M	$1.31B	31.41	9,000
CRD.B Crawford & Company	1.4784 of 5 stars	$9.99 -0.3%	N/A	+2.1%	$488.38M	$1.31B	27.75	9,943
HCSG Healthcare Services Group	3.6671 of 5 stars	$22.42 -4.8%	$24.50 +9.3%	+79.2%	$1.62B	$1.84B	13.03	36,000	Earnings Report
CNXC Concentrix	4.8746 of 5 stars	$21.94 -8.2%	$32.75 +49.3%	-57.5%	$1.46B	$9.83B	N/A	455,000
BV BrightView	1.6963 of 5 stars	$14.16 -0.9%	$14.52 +2.5%	-14.0%	$1.33B	$2.67B	N/A	18,600	News Coverage Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CRD.A) was last updated on 7/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Crawford & Company (CRD.A) Competitors

CRD.A vs. CRD.B, HCSG, CNXC, BV, and WLDN

How does Crawford & Company compare to Crawford & Company?

Summary

How does Crawford & Company compare to Healthcare Services Group?

Summary

How does Crawford & Company compare to Concentrix?

Summary

How does Crawford & Company compare to BrightView?

Summary

How does Crawford & Company compare to Willdan Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRD.A vs. The Competition

Crawford & Company Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Crawford & Company (CRD.A) Competitors

CRD.A vs. CRD.B, HCSG, CNXC, BV, and WLDN

How does Crawford & Company compare to Crawford & Company?

Do analysts recommend CRD.B or CRD.A?

Is CRD.B or CRD.A more profitable?

Do insiders & institutionals believe in CRD.B or CRD.A?

Does the media favor CRD.B or CRD.A?

Is CRD.B or CRD.A a better dividend stock?

Which has more volatility and risk, CRD.B or CRD.A?

Which has higher earnings & valuation, CRD.B or CRD.A?

Summary

How does Crawford & Company compare to Healthcare Services Group?

Do institutionals and insiders hold more shares of CRD.A or HCSG?

Does the media prefer CRD.A or HCSG?

Do analysts recommend CRD.A or HCSG?

Which has better earnings & valuation, CRD.A or HCSG?

Is CRD.A or HCSG more profitable?

Which has more volatility & risk, CRD.A or HCSG?

Summary

How does Crawford & Company compare to Concentrix?

Do insiders & institutionals believe in CRD.A or CNXC?

Which has preferable earnings & valuation, CRD.A or CNXC?

Is CRD.A or CNXC more profitable?

Which has more volatility and risk, CRD.A or CNXC?

Do analysts rate CRD.A or CNXC?

Does the media favor CRD.A or CNXC?

Is CRD.A or CNXC a better dividend stock?

Summary

How does Crawford & Company compare to BrightView?

Is BV or CRD.A more profitable?

Which has more risk & volatility, BV or CRD.A?

Do insiders & institutionals believe in BV or CRD.A?

Which has better earnings and valuation, BV or CRD.A?

Does the media favor BV or CRD.A?

Do analysts recommend BV or CRD.A?

Summary

How does Crawford & Company compare to Willdan Group?

Is WLDN or CRD.A more profitable?

Do insiders and institutionals hold more shares of WLDN or CRD.A?

Do analysts prefer WLDN or CRD.A?

Does the media refer more to WLDN or CRD.A?

Which has higher valuation & earnings, WLDN or CRD.A?

Which has more risk and volatility, WLDN or CRD.A?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRD.A vs. The Competition

Crawford & Company Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools